EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Adverse Effects of Denosumab in Kidney Transplant Recipients: A 20-Year Retrospective Single-Center Observation Study in Central Taiwan

Tsung-Yin Tsai, Zi-Hong You, Shang-Feng Tsai, Ming-Ju Wu, Tung-Min Yu, Ya-Wen Chuang, Yung-Chieh Lin, Ya-Lian Deng, Chiann-Yi Hsu, Cheng-Hsu Chen

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.03.017 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Tsung-Yin Tsai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Division of Nephrology, Department of …. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Drug-Related Side Effects and Adverse Reactions, Hypocalcemia, Kidney Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bone loss can be noted in kidney transplantation recipients (KTRs) and can be related to fracture events. Denosumab, a potent monoclonal antibody to RANK ligand, increases lumbar bone mineral density. However, safety data for denosumab remain limited regarding transplant recipients. Hypocalcemia and increased genital tract infections have been mentioned as adverse effects in KTRs after being prescribed denosumab. METHODS: We retrospectively analyzed the electronic medical records of KTRs during the recent 20 years who had been prescribed antiresorptive therapy and were >18 years old. Medical records and their clinical data were reviewed and analyzed. We compared the frequency of adverse effects between denosumab with other antiresorptive therapies. RESULTS: A total of 70 KTRs were enrolled, with 46 patients being given denosumab and the first injection being noted on October 31, 2014. No significant differences were seen in mortality rate, opportunistic infection, pneumonia, or genitourinary tract infection. One diagnosis of osteonecrosis of the jaw was noted in the denosumab group (2.2%). A higher incidence of hypocalcemia (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsDrug-Related Side Effects and Adverse ReactionsHypocalcemiaKidney TransplantationAdolescentHumansDenosumabRetrospective StudiesTaiwanTransplant Recipients

Substanzen

Bone Density Conservation AgentsDenosumab

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital Chiayi Branch, C…
  • Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital Chiayi Branch, Chiayi, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, T…
  • Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Urology, Hsinchu Branch, MacKay Memorial Hospital, New Taipei, Taiwan.
  • Department of Nursing, Taichung Veterans General Hospital, Taichung, Taiwan.

Zitieren

APA

Tsai, T. Y., You, Z. H., Tsai, S. F., Wu, M. J., Yu, T. M., Chuang, Y. W., Lin, Y. C., Deng, Y. L., Hsu, C. Y., & Chen, C. H. (2023). Adverse Effects of Denosumab in Kidney Transplant Recipients: A 20-Year Retrospective Single-Center Observation Study in Central Taiwan. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.03.017

Vancouver

Tsai TY, You ZH, Tsai SF, Wu MJ, Yu TM, Chuang YW, et al. Adverse Effects of Denosumab in Kidney Transplant Recipients: A 20-Year Retrospective Single-Center Observation Study in Central Taiwan. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.03.017

BibTeX
@article{Tsai2023,
  author = {Tsai, Tsung-Yin and You, Zi-Hong and Tsai, Shang-Feng and Wu, Ming-Ju and Yu, Tung-Min and Chuang, Ya-Wen and Lin, Yung-Chieh and Deng, Ya-Lian and Hsu, Chiann-Yi and Chen, Cheng-Hsu},
  title = {Adverse Effects of Denosumab in Kidney Transplant Recipients: A 20-Year Retrospective Single-Center Observation Study in Central Taiwan},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.03.017}
}
Kostenlos starten →